newsfilter
← Latest News
GlobeNewswire·

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focused on developing the next generation of